| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quince Therapeutics, Inc. (QNCX) has 7 insiders with recent SEC Form 4 filings, including 27 buys and 1 sell. QNCX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 739.9K | $699.2K | - | |
| COO | 45.2K | $42.7K | - | |
| ? | 39.2K | $37.0K | - | |
| ? | 29.4K | $27.8K | - | |
| ? | 21.8K | $20.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2020 | Epiq Capital Group, LLC | Ia/ Managing Member Of 10% Owne | Buy | 9,040 | $44.25 | $400,018.40 | +0.2% | |
| Jun 4, 2020 | Lamond David66 | Director | Buy | 49,125 | $43.27 | $2,125,794.96 | +1.0% | |
| Jun 3, 2020 | Pfizer Inc | 10% Owner | Sell | 370,000 | $40.18 | $14,866,600.00 | -11.4% | |
| May 22, 2020 | Epiq Capital Group, LLC | Ia/ Managing Member Of 10% Owne | Buy | 8,690 | $57.33 | $498,172.24 | - | |
| May 19, 2020 | Lamond David66 | Director | Buy | 44,648 | $55.35 | $2,471,251.33 | +0.3% | |
| Aug 21, 2019 | Epiq Capital Group, LLC | Ia/ Managing Member 10% Owner | Buy | 4,965 | $25.35 | $125,862.67 | - | |
| Aug 19, 2019 | Epiq Capital Group, LLC | Ia/ Managing Member 10% Owner | Buy | 2,800 | $26.46 | $74,099.90 | - | |
| May 13, 2019 | Pfizer Inc | 10% Owner | Buy | 50,000 | $17.00 | $850,000.00 | +1.6% | |
| May 13, 2019 | Young Kevin | Director | Buy | 30,000 | $17.00 | $510,000.00 | New | |
| May 13, 2019 | Ryan Una S | Director | Buy | 2,875 | $17.00 | $48,875.00 | New |